KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Steris (STE) Revenue (2018 - 2025)

Steris has reported Revenue over the past 8 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly results put Revenue at $1.5 billion for Q4 2025, up 9.16% from a year ago — trailing twelve months through Dec 2025 was $5.8 billion (up 7.96% YoY), and the annual figure for FY2025 was $5.5 billion, up 6.24%.
  • Revenue for Q4 2025 was $1.5 billion at Steris, up from $1.5 billion in the prior quarter.
  • Over the last five years, Revenue for STE hit a ceiling of $1.5 billion in Q4 2025 and a floor of $873.5 million in Q1 2021.
  • Median Revenue over the past 5 years was $1.3 billion (2023), compared with a mean of $1.2 billion.
  • Biggest five-year swings in Revenue: soared 58.3% in 2021 and later decreased 8.86% in 2022.
  • Steris' Revenue stood at $1.2 billion in 2021, then fell by 7.99% to $1.1 billion in 2022, then increased by 16.66% to $1.3 billion in 2023, then grew by 5.62% to $1.4 billion in 2024, then increased by 9.16% to $1.5 billion in 2025.
  • The last three reported values for Revenue were $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.